The FDA approved FluMist, a nasal spray flu vaccine for self-administration, making it the first flu vaccine of its kind available for at home use. FluMist, manufactured by drugmaker AstraZeneca, was previously approved in 2003 for healthcare provider administration, with the new approval allowing for adults to administer the vaccine to themselves or their children, according to a Sept.

FDA批准了FluMist，一种用于自我管理的鼻喷雾剂流感疫苗，使其成为第一种可在家中使用的流感疫苗。由制药商阿斯利康（AstraZeneca）生产的FluMist此前于2003年被批准用于医疗保健提供者管理，新的批准允许成年人为自己或孩子接种疫苗。

20 news release. However, the vaccine will not be made available for home delivery until the 2024 flu season, as AstraZeneca works with partners to streamline its rollout. The vaccine is not recommended for pregnant individuals or immunocompromised patients, and the FDA stated that patients will still need to get a prescription for the vaccine from a healthcare provider..

20新闻稿。。该疫苗不建议孕妇或免疫功能低下的患者使用，FDA表示，患者仍需要从医疗保健提供者那里获得疫苗处方。。